These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33588913)

  • 21. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
    Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
    Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of OSBPL3 by HIF1A promotes colorectal cancer progression through activation of RAS signaling pathway.
    Jiao HL; Weng BS; Yan SS; Lin ZM; Wang SY; Chen XP; Liang GH; Li XQ; Zhao WY; Huang JY; Zhang D; Zhang LJ; Han FY; Li SN; Chen LJ; Zhu JH; He WF; Ding YQ; Ye YP
    Cell Death Dis; 2020 Jul; 11(7):571. PubMed ID: 32709922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. tRNA-derived small RNA changes in bone marrow stem cells under hypoxia and osteogenic conduction.
    Zhang C; Ye W; Zhao M; Xia D; Fan Z
    J Oral Rehabil; 2023 Dec; 50(12):1487-1497. PubMed ID: 37574812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; He Q; Yu W
    Gene; 2020 Sep; 754():144851. PubMed ID: 32525044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
    Song L; Huang Y; Zhang X; Han S; Hou M; Li H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
    Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
    Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
    Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
    Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
    Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
    Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2.
    Chen X; Wang AL; Liu YY; Zhao CX; Zhou X; Liu HL; Lin MB
    Oxid Med Cell Longev; 2020; 2020():5316276. PubMed ID: 33414893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.